Base to Base Biotech
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.
Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.
The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.
Base to Base is an Ayr Coastal Media Ltd production.
- Update frequency
- every 6 days
- Average duration
- 49 minutes
- Episodes
- 25
- Years Active
- 2025
Base to Base biotech podcast 25: Molecular glue degradation
This week, we have an in-depth conversation on molecular glue degradation, with Monte Rosa Therapeutics’ chief data and information officer John Castle.
Interview time:
03:52 Monte Rosa Therapeutics
Mol…
Base to Base biotech podcast 24: Dissecting the US cuts to mRNA vaccine projects and Herantis takes on Parkinson’s disease
This week, we look at Herantis Pharma's work on Parkinson's disease, with the company's CEO, Antti Vuolanto, and we have an in-depth look at the recent cuts to mRNA vaccine projects, with Jean Peccou…
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we discuss artificial intelligence, and digitalisation,…
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies
This week, we talk about new treatments for wet dry age-related macular degeneration (AMD) with Judith Greciet, CEO of PulseSight Therapeutics, and there’s a conversation with Maite Agüeros, CEO and …
Base to Base biotech podcast 21: Elix drug discovery platform, and CytoAgents on CAR-T, CRS and the FDA
This week, we talk about drug discovery with Shinya Yuki, co-founder and CEO of Elix Inc., and Teresa Whalen, CEO of CytoAgents, about CAR-T therapies, cytokine release syndrome, and the FDA.
Inter…
Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles
This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terumo Blood and Cell Technologies, and Morten Graugaa…
Base to Base biotech podcast 19: Nipro on dialysis and LenioBio on cell-free protein synthesis
This week’s podcast is sponsored by Nipro.
This week, our conversations are with Jesus Garcia, Nipro Product Manager Water Treatment, on Nipro ’s recently-launched product LiniXia, a reverse osmosis (…
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
This week, we have conversations with Eduardo Bravo, CEO of Citryll, and Dermot Tierney, COO of AMPLY Discovery.
Interview times:
02:53 Citryll
21:56 AMPLY Discovery
Citryll
Citryll’s recent Series B fina…
Base to Base biotech podcast 17: Silico nanoparticle gene delivery, and diagnosing urinary tract infections
This week, our subjects are a silica nanoparticle gene delivery system in a conversation with Nigel Theobald, CEO of N4 Pharma, and a point-of-care diagnostics system for urinary tract infections dev…
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
This week, we have conversations with Sean MacDonald, CEO of Domain Therapeutics, Carina Kern, CEO and founder of LinkGevity, and Nadia Harhen, general manager of AI Simulation at SandboxAQ.
Intervi…
Base to Base biotech podcast 15: Bio-convergence and cancer vaccines
This week, we have conversations with Phil L'Huillier, CEO of Scancell, and Shai Melcer, head of Israel’s National Bio-Convergence Program.
Interview times:
03:25 Scancell
28:04 National Bio-Convergenc…
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
This week, we have conversations with Peter Nolan, CEO of BlackFinBio, and Kim Kraemer, CEO and founder of Waterhouse Brands.
Interview times:
01:57 BlackFinBio
19:36 Waterhouse Brands
BlackFinBio
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
This week, we have conversations with Dr Peter Tummino, president of R&D at Nimbus, and Alex Del Priore, senior vice president, manufacturing at Syngene International Limited.
Interview times:
02:00 Sy…
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism
This week, our guests are Ben Cliff, CEO of UK-based CRO, Concept Life Sciences, and Ravi Rao, chief medical officer of Sitryx.
Interview times
01:12 Sitryx
19:40 CLS
Concept Life Sciences
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
This week, we have a conversation with Ben Zeskind, CEO and co-founder of Immuneering, and a discussion with Tasso Inc.’s co-founder and chief technology officer, Erwin Berthier.
Interview times:
01:27…
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
This week, we have a conversation with Vidmantas Šakalys, CEO of bioprinting company Vital3D Technologies, and a chat with Oriana Papin-Zoghbi, CEO and co-founder of AOA Dx, another of the companies …
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
This week, we’re talking to some of the companies that attended the American Association for Cancer Research (AACR) annual meeting in Chicago.
We have interviews with Microbiotica, 1Cell.Ai, and Tesse…
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
This week on the podcast, we have a conversation with Elise de Reus, the co-founder of Cradle, a biotech startup that is revolutionising protein design, and a chat about improving hospital operations…
Base to Base biotech podcast 7: The DSCSA deadline and MoonLake's Nanobody
This week on the podcast, we have a conversation with Tim Tinnel, executive vice president/chief operating officer of Intelliguard, talking about – among other things – the looming Drug Supply Chain …
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme
This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, about treating chronic low back pain, and with Monika Paulė, CEO and co-founder of Caszyme.
Intervie…